Tacrolimus-induced apoptotic signal transduction pathway

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Tacrolimus (FK506) is a widely used immunosuppressant.
• Understanding its effects on T lymphocyte signaling pathways is crucial.

Purpose of the Study:

• To investigate the impact of FK506 on apoptotic signaling pathways in Jurkat human T lymphocytes.
• To analyze FK506's effects on cell viability, apoptosis, protein expression, and reactive oxygen species (ROS) generation.

Main Methods:

• Jurkat cells were treated with FK506.
• Flow cytometry was used to assess cell viability and cell cycle.
• Western blotting analyzed protein expression (Bcl-2, Bak, Fas, Fas-L, CDK4, cyclin D1).
• Caspase activity, ROS generation, and mitochondrial membrane potential were measured.

Main Results:

• FK506 decreased Jurkat cell viability in a dose- and time-dependent manner.
• FK506 induced G0/G1 cell cycle arrest and apoptosis, marked by nuclear fragmentation and caspase-3 activation.
• Increased Bak, CDK4, and cyclin D1 expression were observed, while Bcl-2, Fas, and Fas-L remained unchanged.
• FK506-induced cytotoxicity involved ROS generation, modulating Bak expression and mitochondrial dysfunction.

Conclusions:

• FK506 induces apoptosis and G0/G1 cell cycle arrest in Jurkat T lymphocytes.
• Caspase-3 activation, ROS generation, Bak modulation, and mitochondrial dysfunction are key mechanisms in FK506-induced cell death.